There are almost a quarter of a million people in New Zealand diagnosed with diabetes and another 100,000 who have it but don't know.
Diabetic annual reviews (DARs) are a structured way of monitoring patients who have diabetes. A DAR can reduce the risk of complications for patients.
Goals 10 and 11
HbA1c goals are about a planned and proactive approach for patients living with a long-term condition.
It's important patients try to develop good glucose control after diagnosis. For most people with Type 2 diabetes the closer they can get their HbA1c to the 'normal' range, the better the outcome will be for them.
Goals 12 and 13
Kathy joined Pinnacle earlier this month as clinical diabetes specialist for Waikato, replacing the role previously held by Anne Waterman.
Read morePharmac is now allowing new special authority applications for liraglutide (Victoza) from 1 March 2025. The special authority criteria will be the same as when special authorities were suspended in May 2024. This will again allow prescribing according to national guidelines and best practice. Pharmac has assured the intention is for no further suspensions of special authority criteria for GLP-1 agonists to allow ongoing access for those who meet criteria. To ensure availability, it continues to be important these medications are only prescribed for people with type 2 diabetes mellitus (T2DM). Please contact the Pinnacle diabetes lead in your area if you have any questions.
Read moreThe clinical diabetes specialist in primary care provides clinical mentorship and advice to the practice team in supporting patients with diabetes.
View detailsA guide for clinical management of type 2 diabetes, to support nurses at all levels to develop their knowledge and clinical reasoning in diabetes care.